HIV Screening Clinical Guidelines Implementation Guide
0.1.0 - CI Build
Unknown region code '840'
HIV Screening Clinical Guidelines Implementation Guide, published by National Association of Community Health Centers, Inc. (NACHC). This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/hiv-cds/ and changes regularly. See the Directory of published versions
Draft as of 2024-08-12 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="nachc-g2-de7"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet nachc-g2-de7</b></p><a name="nachc-g2-de7"> </a><a name="hcnachc-g2-de7"> </a><a name="nachc-g2-de7-en-US"> </a><ul><li>Include these codes as defined in <a href="http://www.nlm.nih.gov/research/umls/rxnorm"><code>http://www.nlm.nih.gov/research/umls/rxnorm</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>1727491</td><td>emtricitabine / tenofovir alafenamide</td></tr><tr><td>1747688</td><td>emtricitabine / tenofovir alafenamide Oral Product</td></tr><tr><td>1747689</td><td>emtricitabine / tenofovir alafenamide Pill</td></tr><tr><td>1747690</td><td>emtricitabine / tenofovir alafenamide Oral Tablet</td></tr><tr><td>1747691</td><td>emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet</td></tr><tr><td>1747693</td><td>emtricitabine 200 MG / tenofovir alafenamide 25 MG [Descovy]</td></tr><tr><td>1747694</td><td>emtricitabine / tenofovir alafenamide Oral Tablet [Descovy]</td></tr><tr><td>1747697</td><td>emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet [Descovy]</td></tr></table></li></ul></div>
</text>
<url value="http://fhir.org/guides/nachc/hiv-cds/ValueSet/nachc-g2-de7"/>
<version value="0.1.0"/>
<name value="TAF25mgFTC200mgOrderCodes"/>
<title value="TAF 25mg / FTC 200mg Order Codes"/>
<status value="draft"/>
<experimental value="false"/>
<date value="2024-08-12T19:50:21+00:00"/>
<publisher
value="National Association of Community Health Centers, Inc. (NACHC)"/>
<contact>
<telecom>
<system value="url"/>
<value value="https://www.nachc.org/"/>
</telecom>
</contact>
<description
value="Codes representing possible values for the TAF 25mg / FTC 200mg Order element"/>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="840"/>
</coding>
</jurisdiction>
<immutable value="true"/>
<copyright
value="Copyright National Association of Community Health Centers, Inc. (NACHC)"/>
<compose>
<include>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<concept>
<code value="1727491"/>
<display value="emtricitabine / tenofovir alafenamide"/>
</concept>
<concept>
<code value="1747688"/>
<display value="emtricitabine / tenofovir alafenamide Oral Product"/>
</concept>
<concept>
<code value="1747689"/>
<display value="emtricitabine / tenofovir alafenamide Pill"/>
</concept>
<concept>
<code value="1747690"/>
<display value="emtricitabine / tenofovir alafenamide Oral Tablet"/>
</concept>
<concept>
<code value="1747691"/>
<display
value="emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet"/>
</concept>
<concept>
<code value="1747693"/>
<display
value="emtricitabine 200 MG / tenofovir alafenamide 25 MG [Descovy]"/>
</concept>
<concept>
<code value="1747694"/>
<display
value="emtricitabine / tenofovir alafenamide Oral Tablet [Descovy]"/>
</concept>
<concept>
<code value="1747697"/>
<display
value="emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet [Descovy]"/>
</concept>
</include>
</compose>
</ValueSet>